ARTG 400441Blood gas syringe/needle, lithium heparin
ARTG ID: 400441 · Smiths Medical Australasia Pty Ltd · Smiths Medical ASD Inc · Class IIa · Started December 01, 2022
Good Name: Smiths Medical Australasia Pty Ltd - Blood gas syringe/needle, lithium heparin
- Risk Class
- Class IIa
- Product Type
- Single Device Product
- ARTG Category
- General
- ARTG ID
- 400441
- Start Date
- December 01, 2022
- Effective Date
- December 01, 2022
- Country
- United States of America
- Address
- 6000 Nathan Lane North , Minneapolis, MN, 55442
A sterile plastic syringe with plunger, and a pre-attached needle, that may contain the anticoagulant lithium heparin and is intended to be used for the collection, and preservation and/or transport, of blood for blood gas determination and/or other investigation. The needle is typically removed after sampling and replaced with a cap or stopper for transport. This is a single-use device.
Access comprehensive regulatory information for Blood gas syringe/needle, lithium heparin in the Australia medical device market through Pure Global AI's free TGA ARTG database. This Class IIa is registered under ARTG number 400441 and sponsored by Smiths Medical Australasia Pty Ltd, manufactured by Smiths Medical ASD Inc in United States of America. The device registration started on December 01, 2022.
This page provides complete registration details including sponsor information, manufacturer details, and regulatory compliance data from the official Australia TGA ARTG medical device database. Pure Global AI offers free access to Australia's complete medical device registry with 131,000+ devices, helping global MedTech companies navigate TGA regulations efficiently.